Dartmouth-Hitchcock logo
Back
 
2018 Diabetes Guideline Update: Controversies and New Recommendations

This module will review updates to the 2018 American Diabetes Association Standards of Medical Care in Diabetes, and how they are reflected in the D-H Knowledge Map Diabetes Clinical Practice Guideline. Dr. Brackett will discuss controversies about blood pressure and Hgb A1c targets, and present information on SGLT-2 and GLP-1 classes of drugs.

Activity Details
Start Date: April 12, 2018
End Date: April 12, 2019
Presenter
  • Charles Brackett, MD, MPH
    Assistant Professor of Medicine, Geisel School of Medicine
    Assistant Professor of The Dartmouth Institute, Geisel School of Medicine
Registration

There is no fee for this activity, but to receive credit you must register online and complete the online evaluation (you must register to access).

Learning Outcome(s)

Based on the 2018 American Diabetes Association Standards of Medical Care in Diabetes, learners will be able to formulate and implement best practice treatment modalities when caring for patients with diabetes.

Accreditation

Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Dartmouth-Hitchcock designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Successful Completion

In order to receive credit for this Continuing Medical Education (CME) activity, you must:

  • View the entire presentation
  • Complete the activity evaluation. (you must register to access).
Speaker Disclosure

The Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for 2018 Diabetes Guideline Update: Controversies and New Recommendations have reported NO financial interest or relationship* which could be perceived as a real or apparent conflict of interest. There were no individuals in a position to control the content that refused to disclose.

In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.

*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:
Center for Learning and Professional Development
Dartmouth-Hitchcock Medical Center
clpd.support@hitchcock.org

For more information on this topic, please go to: http://www.diabetes.org/newsroom/press-releases/2017/american-diabetes-association-2018-release-standards-of-medical-care-in-diabetes.html


Type:     Internet Activity (Enduring Material)
22 Registered Users

0